RGP1
gene geneOn this page
Summary
RGP1 (RGP1 partner of RAB6A GEF complex, HGNC:21965) is a protein-coding gene on chromosome 9p13.3, encoding RAB6A-GEF complex partner protein 2 (Q92546). The RIC1-RGP1 complex acts as a guanine nucleotide exchange factor (GEF), which activates RAB6A by exchanging bound GDP for free GTP and may thereby required for efficient fusion of endosome-derived vesicles with the Golgi compartment. It is a selective cancer dependency (DepMap: 44.0% of cell lines).
Enables guanyl-nucleotide exchange factor activity and small GTPase binding activity. Involved in negative regulation of protein catabolic process; positive regulation of GTPase activity; and retrograde transport, endosome to Golgi. Located in cytosol and plasma membrane. Part of Ric1-Rgp1 guanyl-nucleotide exchange factor complex.
Source: NCBI Gene 9827 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 63 total
- Cancer dependency (DepMap): dependent in 44.0% of screened cell lines
- MANE Select transcript:
NM_001080496
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21965 |
| Approved symbol | RGP1 |
| Name | RGP1 partner of RAB6A GEF complex |
| Location | 9p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000107185 |
| Ensembl biotype | protein_coding |
| OMIM | 615742 |
| Entrez | 9827 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 5 protein_coding, 1 retained_intron
ENST00000378078, ENST00000496906, ENST00000880976, ENST00000880977, ENST00000931309, ENST00000965086
RefSeq mRNA: 1 — MANE Select: NM_001080496
NM_001080496
CCDS: CCDS47964
Canonical transcript exons
ENST00000378078 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000699418 | 35750658 | 35750741 |
| ENSE00000699421 | 35750840 | 35750989 |
| ENSE00001476210 | 35749287 | 35749408 |
| ENSE00001929561 | 35752651 | 35758585 |
| ENSE00003467286 | 35749737 | 35749871 |
| ENSE00003492519 | 35751627 | 35751754 |
| ENSE00003529146 | 35751266 | 35751412 |
| ENSE00003615089 | 35750243 | 35750379 |
| ENSE00003635275 | 35751956 | 35752145 |
Expression profiles
Bgee: expression breadth ubiquitous, 279 present calls, max score 98.93.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 16.7619 / max 79.2193, expressed in 1799 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 96628 | 16.4018 | 1799 |
| 96629 | 0.3601 | 175 |
Top tissues by expression
290 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| tendon of biceps brachii | UBERON:0008188 | 98.93 | gold quality |
| medial globus pallidus | UBERON:0002477 | 91.81 | gold quality |
| pylorus | UBERON:0001166 | 91.01 | gold quality |
| renal medulla | UBERON:0000362 | 90.88 | gold quality |
| nipple | UBERON:0002030 | 90.37 | gold quality |
| globus pallidus | UBERON:0001875 | 89.82 | gold quality |
| cardia of stomach | UBERON:0001162 | 88.63 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 88.61 | silver quality |
| body of tongue | UBERON:0011876 | 88.30 | gold quality |
| saphenous vein | UBERON:0007318 | 87.97 | gold quality |
| gluteal muscle | UBERON:0002000 | 87.20 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 86.72 | gold quality |
| islet of Langerhans | UBERON:0000006 | 86.51 | gold quality |
| vena cava | UBERON:0004087 | 86.46 | silver quality |
| tongue | UBERON:0001723 | 86.45 | gold quality |
| parotid gland | UBERON:0001831 | 86.08 | gold quality |
| stromal cell of endometrium | CL:0002255 | 86.06 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 86.04 | gold quality |
| superior surface of tongue | UBERON:0007371 | 86.04 | gold quality |
| triceps brachii | UBERON:0001509 | 86.01 | silver quality |
| gastrocnemius | UBERON:0001388 | 85.38 | gold quality |
| ventral tegmental area | UBERON:0002691 | 85.33 | gold quality |
| dorsal motor nucleus of vagus nerve | UBERON:0002870 | 85.04 | gold quality |
| pons | UBERON:0000988 | 85.01 | gold quality |
| muscle of leg | UBERON:0001383 | 85.01 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 84.78 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 84.55 | gold quality |
| medulla oblongata | UBERON:0001896 | 84.22 | gold quality |
| muscle organ | UBERON:0001630 | 84.05 | gold quality |
| rectum | UBERON:0001052 | 83.86 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.49 |
Regulation
Is transcription factor: no
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 44.0% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 1)
- Ric1-Rgp1 complex is a guanine nucleotide exchange factor for the late Golgi Rab6A GTPase and an effector of the medial Golgi Rab33B GTPase. (PMID:23091056)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | rgp1 | ENSDARG00000006545 |
| mus_musculus | Rgp1 | ENSMUSG00000028468 |
| rattus_norvegicus | Rgp1 | ENSRNOG00000016309 |
| drosophila_melanogaster | CG1116 | FBGN0037297 |
| caenorhabditis_elegans | WBGENE00010815 |
Protein
Protein identifiers
RAB6A-GEF complex partner protein 2 — Q92546 (reviewed: Q92546)
Alternative names: Retrograde Golgi transport protein RGP1 homolog
All UniProt accessions (1): Q92546
UniProt curated annotations — full annotation on UniProt →
Function. The RIC1-RGP1 complex acts as a guanine nucleotide exchange factor (GEF), which activates RAB6A by exchanging bound GDP for free GTP and may thereby required for efficient fusion of endosome-derived vesicles with the Golgi compartment. The RIC1-RGP1 complex participates in the recycling of mannose-6-phosphate receptors.
Subunit / interactions. Forms a complex with RIC1; the interaction enhances RAB6A GTPase activity. Interacts with RIC1. Interacts with RAB6A; the interaction is direct with a preference for RAB6A-GDP. Interacts with RAB33B.
Subcellular location. Cytoplasm. Cytosol. Membrane.
Similarity. Belongs to the RGP1 family.
RefSeq proteins (1): NP_001073965* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR014848 | Rgp1 | Family |
Pfam: PF08737
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q92546-F1 | 85.74 | 0.58 |
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-6811438 | Intra-Golgi traffic |
| R-HSA-6811440 | Retrograde transport at the Trans-Golgi-Network |
| R-HSA-8876198 | RAB GEFs exchange GTP for GDP on RABs |
MSigDB gene sets: 119 (showing top):
YAGI_AML_WITH_INV_16_TRANSLOCATION, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOBP_REGULATION_OF_GTPASE_ACTIVITY, GOBP_VESICLE_MEDIATED_TRANSPORT, REACTOME_MEMBRANE_TRAFFICKING, GOMF_GTPASE_BINDING, GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS, HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP, GOBP_POSITIVE_REGULATION_OF_CATALYTIC_ACTIVITY, GOBP_REGULATION_OF_HYDROLASE_ACTIVITY, GOCC_TRANS_GOLGI_NETWORK, GOBP_POSITIVE_REGULATION_OF_MOLECULAR_FUNCTION, GOBP_REGULATION_OF_CATABOLIC_PROCESS, chr9p13, GOBP_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS
GO Biological Process (3): retrograde transport, endosome to Golgi (GO:0042147), negative regulation of protein catabolic process (GO:0042177), positive regulation of GTPase activity (GO:0043547)
GO Molecular Function (3): guanyl-nucleotide exchange factor activity (GO:0005085), small GTPase binding (GO:0031267), protein binding (GO:0005515)
GO Cellular Component (8): Golgi membrane (GO:0000139), cytosol (GO:0005829), plasma membrane (GO:0005886), membrane (GO:0016020), trans-Golgi network membrane (GO:0032588), protein-containing complex (GO:0032991), Ric1-Rgp1 guanyl-nucleotide exchange factor complex (GO:0034066), cytoplasm (GO:0005737)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Intra-Golgi and retrograde Golgi-to-ER traffic | 2 |
| Rab regulation of trafficking | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| Golgi apparatus | 2 |
| intercellular transport | 1 |
| endosomal transport | 1 |
| cytosolic transport | 1 |
| negative regulation of catabolic process | 1 |
| protein catabolic process | 1 |
| regulation of protein catabolic process | 1 |
| negative regulation of protein metabolic process | 1 |
| GTPase activity | 1 |
| regulation of GTPase activity | 1 |
| positive regulation of hydrolase activity | 1 |
| GTP binding | 1 |
| GDP binding | 1 |
| GTPase regulator activity | 1 |
| GTPase binding | 1 |
| binding | 1 |
| bounding membrane of organelle | 1 |
| cytoplasm | 1 |
| membrane | 1 |
| cell periphery | 1 |
| trans-Golgi network | 1 |
| organelle membrane | 1 |
| cellular_component | 1 |
| guanyl-nucleotide exchange factor complex | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
776 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RGP1 | YBEY | P58557 | 605 |
| RGP1 | C1S | P09871 | 488 |
| RGP1 | POMGNT1 | Q8WZA1 | 393 |
| RGP1 | CBX7 | O95931 | 349 |
| RGP1 | RIC1 | Q4ADV7 | 349 |
| RGP1 | NSD2 | O96028 | 301 |
| RGP1 | VPS52 | Q8N1B4 | 287 |
| RGP1 | VPS53 | Q5VIR6 | 253 |
| RGP1 | RAB6B | Q9NRW1 | 246 |
| RGP1 | RAB6A | P20340 | 246 |
| RGP1 | RAB41 | Q5JT25 | 246 |
| RGP1 | RAB6C | Q9H0N0 | 246 |
| RGP1 | TRAPPC5 | Q8IUR0 | 240 |
| RGP1 | MGAT1 | P26572 | 224 |
| RGP1 | TRAPPC13 | A5PLN9 | 214 |
IntAct
40 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RGP1 | RIC1 | psi-mi:“MI:0915”(physical association) | 0.700 |
| RIC1 | RGP1 | psi-mi:“MI:0915”(physical association) | 0.700 |
| RGP1 | RIC1 | psi-mi:“MI:0407”(direct interaction) | 0.700 |
| RAB33B | RIC1 | psi-mi:“MI:0914”(association) | 0.590 |
| RAB6A | RIC1 | psi-mi:“MI:0914”(association) | 0.590 |
| RGP1 | RAB6A | psi-mi:“MI:0407”(direct interaction) | 0.580 |
| RGP1 | RAB6A | psi-mi:“MI:0914”(association) | 0.580 |
| RGP1 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| RGP1 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| RFPL3 | RGP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RGP1 | tax | psi-mi:“MI:0915”(physical association) | 0.560 |
| tax | RGP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SOCS3 | RGP1 | psi-mi:“MI:0914”(association) | 0.530 |
| EMILIN1 | METTL15 | psi-mi:“MI:0914”(association) | 0.530 |
| rep | RGP1 | psi-mi:“MI:0915”(physical association) | 0.490 |
| CCDC102B | TARSL2 | psi-mi:“MI:0914”(association) | 0.350 |
| GTSF1 | MAPK14 | psi-mi:“MI:0914”(association) | 0.350 |
| SOCS3 | PLS1 | psi-mi:“MI:0914”(association) | 0.350 |
| SYNGR1 | TNPO2 | psi-mi:“MI:0914”(association) | 0.350 |
| ETNK2 | ZNF185 | psi-mi:“MI:0914”(association) | 0.350 |
| C1orf210 | SPAG9 | psi-mi:“MI:0914”(association) | 0.350 |
| CACNG3 | NOTCH2 | psi-mi:“MI:0914”(association) | 0.350 |
| EPHA1 | ENC1 | psi-mi:“MI:0914”(association) | 0.350 |
| OCIAD1 | DCTN6 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (30): NBPF22P (Two-hybrid), RGP1 (Synthetic Lethality), RGP1 (Affinity Capture-MS), RGP1 (Affinity Capture-MS), RGP1 (Affinity Capture-MS), RGP1 (Proximity Label-MS), RFPL3 (Two-hybrid), RGP1 (Proximity Label-MS), RGP1 (Proximity Label-MS), RGP1 (Proximity Label-MS), RGP1 (Proximity Label-MS), RGP1 (Proximity Label-MS), RGP1 (Affinity Capture-RNA), RGP1 (Proximity Label-MS), RGP1 (Affinity Capture-MS)
ESM2 similar proteins: A0A0B4J1F4, A0A0G2JXN2, A2AWP8, A2RRH5, C9J798, O43374, O70277, O95294, P04629, P59926, Q0GA42, Q13368, Q14318, Q16512, Q29RM4, Q2HY40, Q2T9P3, Q2TBA3, Q5BIM1, Q5M7W1, Q5R5M3, Q5R811, Q5T7P8, Q5XIS9, Q62746, Q6PFQ7, Q6PFY8, Q7TNM2, Q7TP90, Q7Z4K8, Q8BG60, Q8BHT7, Q8BQC3, Q8C6N3, Q8CIW5, Q8IZ69, Q8NCT1, Q920N2, Q92546, Q925B4
Diamond homologs: Q2T9P3, Q8BHT7, Q92546
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
63 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 54 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1432 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:35750238:CACA:C | acceptor_loss | 1.0000 |
| 9:35750240:CAG:C | acceptor_loss | 1.0000 |
| 9:35750241:A:AG | acceptor_gain | 1.0000 |
| 9:35750241:AGT:A | acceptor_gain | 1.0000 |
| 9:35750242:G:A | acceptor_loss | 1.0000 |
| 9:35750242:G:GA | acceptor_gain | 1.0000 |
| 9:35750242:GT:G | acceptor_gain | 1.0000 |
| 9:35750242:GTG:G | acceptor_gain | 1.0000 |
| 9:35750242:GTGA:G | acceptor_gain | 1.0000 |
| 9:35750377:GAGG:G | donor_loss | 1.0000 |
| 9:35750378:AGG:A | donor_loss | 1.0000 |
| 9:35750379:GGTTA:G | donor_loss | 1.0000 |
| 9:35750380:GTT:G | donor_loss | 1.0000 |
| 9:35750654:TCAG:T | acceptor_loss | 1.0000 |
| 9:35750655:CAGG:C | acceptor_loss | 1.0000 |
| 9:35750656:AGG:A | acceptor_loss | 1.0000 |
| 9:35751413:G:GG | donor_gain | 1.0000 |
| 9:35749454:A:T | donor_gain | 0.9900 |
| 9:35749732:TCTAG:T | acceptor_loss | 0.9900 |
| 9:35749733:CTAGA:C | acceptor_loss | 0.9900 |
| 9:35749734:TAGA:T | acceptor_loss | 0.9900 |
| 9:35749735:A:AG | acceptor_gain | 0.9900 |
| 9:35749736:G:GG | acceptor_gain | 0.9900 |
| 9:35749736:G:GT | acceptor_loss | 0.9900 |
| 9:35749823:T:TA | donor_gain | 0.9900 |
| 9:35749824:A:AA | donor_gain | 0.9900 |
| 9:35749870:AG:A | donor_loss | 0.9900 |
| 9:35749871:GG:G | donor_loss | 0.9900 |
| 9:35749872:GTGGG:G | donor_loss | 0.9900 |
| 9:35749873:T:A | donor_loss | 0.9900 |
AlphaMissense
2491 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:35750256:T:A | W44R | 1.000 |
| 9:35750256:T:C | W44R | 1.000 |
| 9:35750258:G:C | W44C | 1.000 |
| 9:35750258:G:T | W44C | 1.000 |
| 9:35750266:C:A | A47D | 1.000 |
| 9:35750259:G:C | A45P | 0.999 |
| 9:35750260:C:A | A45D | 0.999 |
| 9:35750262:A:C | S46R | 0.999 |
| 9:35750264:T:A | S46R | 0.999 |
| 9:35750264:T:G | S46R | 0.999 |
| 9:35750269:A:C | Q48P | 0.999 |
| 9:35750277:T:C | C51R | 0.999 |
| 9:35750279:C:G | C51W | 0.999 |
| 9:35750697:T:C | I98T | 0.999 |
| 9:35750697:T:G | I98S | 0.999 |
| 9:35750700:T:C | L99P | 0.999 |
| 9:35750706:G:A | C101Y | 0.999 |
| 9:35750712:T:C | L103P | 0.999 |
| 9:35750718:T:A | L105H | 0.999 |
| 9:35750845:T:G | Y115D | 0.999 |
| 9:35750897:T:A | V132D | 0.999 |
| 9:35750902:T:G | Y134D | 0.999 |
| 9:35750915:T:C | L138P | 0.999 |
| 9:35750921:T:A | I140N | 0.999 |
| 9:35750924:G:A | G141D | 0.999 |
| 9:35751963:T:A | V257D | 0.999 |
| 9:35752662:T:A | W322R | 0.999 |
| 9:35752662:T:C | W322R | 0.999 |
| 9:35749819:T:C | C22R | 0.998 |
| 9:35749832:T:A | V26D | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000092662 (9:35763825 T>G), RS1000111753 (9:35764908 G>T), RS1000120959 (9:35778343 C>A,T), RS1000243732 (9:35790519 C>G), RS1000318678 (9:35758183 T>G), RS1000358774 (9:35790121 T>C), RS1000387085 (9:35789473 G>A), RS1000423369 (9:35764261 G>A,T), RS1000528887 (9:35769696 A>T), RS1000586955 (9:35783600 A>G), RS1000690639 (9:35747607 A>C), RS1000699518 (9:35753765 G>A,T), RS1000712043 (9:35783577 T>C), RS1000751991 (9:35753433 G>A), RS1000926582 (9:35778510 C>A)
Disease associations
OMIM: gene MIM:615742 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010703_52 | Brain morphology (MOSTest) | 1.000000e-08 |
| GCST012227_49 | Hip circumference adjusted for BMI | 4.000000e-08 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004346 | neuroimaging measurement |
| EFO:0008039 | BMI-adjusted hip circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| dicrotophos | increases expression | 1 |
| N,N,N’,N’-tetrakis(2-pyridylmethyl)ethylenediamine | decreases expression | 1 |
| abrine | increases expression | 1 |
| Temozolomide | affects response to substance | 1 |
| Sunitinib | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Carmustine | affects response to substance | 1 |
| Doxorubicin | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Zinc Sulfate | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_E2J7 | HAP1 RGP1 (-) | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.